JHS — JHS Svendgaard Laboratories Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹1.38bn
- IN₹1.33bn
- IN₹962.07m
- 34
- 32
- 33
- 19
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | Interim Report |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 56.9 | 69.5 | 230 | 80.2 | 387 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 759 | 1,093 | 712 | 408 | 261 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,016 | 1,302 | 1,210 | 790 | 858 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 744 | 715 | 710 | 773 | 728 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2,212 | 2,409 | 2,280 | 2,220 | 2,292 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 387 | 484 | 231 | 189 | 377 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 443 | 629 | 393 | 361 | 554 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1,768 | 1,780 | 1,887 | 1,859 | 1,738 |
Total Liabilities & Shareholders' Equity | 2,212 | 2,409 | 2,280 | 2,220 | 2,292 |
Total Common Shares Outstanding |